Hepatic IL-1 signaling in NAFLD is a driver of whole-body insulin resistance and adipose tissue inflammation

Authors :: Ari Waisman
N Gehrke
Detlef Schuppan
PR Galle
JM Schattenberg
MA Wörns
Beate K. Straub
Source :: Zeitschrift für Gastroenterologie.
Publication Year :: 2020
Publisher :: Georg Thieme Verlag KG, 2020.

Subjects :: medicine.medical_specialty
Insulin resistance
Endocrinology
business.industry
Internal medicine
Medicine
Adipose tissue
Inflammation
medicine.symptom
business
Whole body
medicine.disease

Full Text Access

Tools